DCI COVID-19 Surveillance Project
Completed · Not applicable
Conditions studied: Covid19
In brief
This is a prospective longitudinal census study conducted at a single center (DCI Inc., Henry Avenue, Philadelphia). The purpose of this study is to gain information about COVID-19 infection and antibody response in an in-center dialysis population. The investigators hypothesize that screening and surveillance for COVID-19 positive test (viral infection) and antibodies response to infection (potential immunity) in a dialysis center population within a high-prevalence region can provide foundational information to guide approaches toward prevention of COVID-19 related illness in a susceptible population. Participants will be given a questionnaire initially and monthly over the study period to find out whether they have had COVID-19 infection, hospitalization, or symptoms. A nasopharyngeal swab test for COVID-19 infection and a blood sample for COVID-19 antibody will be collected monthly for the study period.
Key facts
- Study ID
- NCT04780698
- Run by
- Temple University
- People needed
- 30
- Starts
- 2021-02-12
- Expected to finish
- 2022-10-13
- Last updated by the study team
- 2023-02-16
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients who receive in-center chronic dialysis (>3 months) at DCI Henry Avenue
- Patients who are able to consent for study
You may not qualify if…
- Patients receiving transient hemodialysis at DCI or receiving hemodialysis for Acute Renal Failure
- Patients who are unable to consent
- Patients who are receiving other forms of dialysis therapy (e.g. home hemodialysis, peritoneal dialysis)
- Patients whose life expectancy is <12 months
- Patients who are planning to leave the dialysis center within 12 months
Where it is running
- Dialysis Clinic, Inc. — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.